The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
Abstract
DNA microarrays have made it possible to estimate the level of expression of thousands of genes for a sample of cells. Although biomedical investigators have been quick to adopt this powerful new research tool, accurate analysis and interpretation of the data have provided unique challenges. Indeed, many investigators are not experienced in the analytical steps needed to convert tens of thousands of noisy data points into reliable and interpretable biologic information. Although some investigators recognize the importance of collaborating with experienced biostatisticians to analyze microarray data, the number and availability of experienced biostatisticians is inadequate. Consequently, investigators are using available software to analyze their data, many seemingly without knowledge of potential pitfalls. Because of serious problems associated with the analysis and reporting of some DNA microarray studies, there is great interest in guidance on valid and effective methods for analysis of DNA microarray data. The design and analysis strategy for a DNA microarray experiment should be determined in light of the overall objectives of the study. Because DNA microarrays are used for a wide variety of objectives, it is not feasible to address the entire range of design and analysis issues in this commentary. Here, we address statistical issues that arise from the use of DNA microarrays for an important group of objectives that has been called “class prediction” (1). Class prediction includes derivation of predictors of prognosis, response to therapy, or any phenotype or genotype defined independently of the gene expression profile. Good DNA microarray experiments, although not based on gene-specific mechanistic hypotheses, should be planned and conducted with clear objectives. Three commonly encountered types of study objectives are “class comparison,” “class prediction,” and “class discovery” (1). Class comparison is the comparison of gene expression in different groups of specimens. The major characteristic of class comparison studies is that the classes being compared are defined independently of the expression profiles. The specific objectives of such a study are to determine whether the expression profiles are different between the classes and, if so, to identify the differentially expressed genes. One example of a class comparison study is the comparison of gene expression profiles of stage I breast cancer patients who are long-term survivors with the gene expression profiles of those who have recurrent disease. Another example is the comparison between gene expression profiles in breast cancer patients with and without germline BRCA1 mutations (2). Class prediction studies are similar to class comparison studies in that the classes are predefined. In class prediction studies, however, the emphasis is on developing a gene expression-based multivariate function (referred to as the predictor) that accurately predicts the class membership of a new sample on the basis of the expression levels of key genes. Such predictors can be used for many types of clinical management decisions, including risk assessment, diagnostic testing, prognostic stratification, and treatment selection. Many studies include both class comparison and class prediction objectives. Class discovery is fundamentally different from class comparison or class prediction in that no classes are predefined. Usually the purpose of class discovery in cancer studies is to determine whether discrete subsets of a disease entity can be defined on the basis of gene expression profiles. This purpose is different from determining whether the gene expression profiles correlate with some already known diagnostic classification. Examples of class discovery are the studies by Bittner et al. (3) that examined gene expression profiles for advanced melanomas and by Alizadeh et al. (4) that examined the gene expression profiles of patients with diffuse large B-cell lymphoma. Often the purpose of class discovery is to identify clues regarding the heterogeneity of disease pathogenesis. One of the most common errors in the analysis of DNA microarray data is the use of cluster analysis and simple fold change statistics for problems of class comparison and class prediction. Although cluster analysis is appropriate for class discovery, it is often not effective for class comparison or class prediction. Cluster analysis refers to an extensive set of methods for partitioning samples into groups on the basis of the similarities and differences (referred to as distances) among their gene expression profiles. Because there are many ways of measuring distances among gene expression profiles involving thousands of genes and because there are many algorithms for partitioning, cluster analysis is a very subjective analysis strategy. Cluster analysis is considered an unsupervised method of analysis because no information about sample grouping is used. The distance measures are ge
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine · doi:10.1038/89044 · Cited by 2,644
Cited by
Bias in error estimation when using cross-validation for model selection
Varma, S., & Simon, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-91 · Cited by 2,485
“[2], Ambroise and McLachlan [3] and Reunanen [4], this gives a very biased estimate of the true error; not much better than the resubstitution estimate.”
Self-citationPredictive data mining in clinical medicine: Current issues and guidelines
BELLAZZI, R., & ZUPAN, B. (2008) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2006.11.006 · Cited by 823
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
Dupuy, A., & Simon, R. M. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk018 · Cited by 632
Self-citationEschrich, S. A., Pramana, J., Zhang, H., Zhao, H., Boulware, D., Lee, J.-H., Bloom, G., Rocha-Lima, C., Kelley, S., Calvin, D. P., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.014 · Cited by 360
Metadata
- Authors
- Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 14-18
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2043235003
- Cited by
- 1,006
- References
- 2
- FWCI
- 28.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification. https://app.cochat.ai/papers/10.1093/jnci/95.1.14
- The paper
- Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003). Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/95.1.14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.